[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100320242":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":32,"responsibleParty":52,"collaborators":20,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":20,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":20,"overallStatus":35,"whyStopped":20,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Institut du Cancer de Montpellier - Val d'Aurelle","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Biological collection","EXPERIMENTAL","samples of different natures:\n\n* Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery.\n* Blood samples taken at different times. During the blood samples taken for diagnosis and \u002F or treatment, additional samples for research purposes will be carried out.\n\nIn parallel to this biological collection, standardized clinical data will be entered into a database",[13],"Biological: biological collection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","biological collection","* Tissue samples (tumor tissue and healthy tissue) frozen and secured in paraffin collected during surgery.\n* Blood samples taken at different times. During the blood samples taken for diagnosis and \u002F or treatment, additional samples for research purposes will be carried out.",[9],null,[22],{"name":23,"affiliation":24,"role":25},"jean pierre Bleuse","Institut régional du Cancer de Montpellier","STUDY_CHAIR",[27],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"david azria","CONTACT","+33467613102","david.azria@icm.unicancer.fr",[33],{"facility":34,"status":35,"city":36,"state":20,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Institut regional du Cancer - Val d Aurelle","RECRUITING","Montpellier","34298","France","FR",{"type":41,"coordinates":42},"Point",[43,44],3.87635,43.61093,{"lat":44,"lon":43},[47,49],{"name":48,"role":29,"phone":20,"phoneExt":20,"email":20},"BLEUSE Jean-pierre, MHD",{"name":50,"role":51,"phone":20,"phoneExt":20,"email":20},"AZRIA David, PhD","PRINCIPAL_INVESTIGATOR",{"type":53,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100320242","development-of-clinical-and-biological-database-100320242",false,"NCT03449264","Development of Clinical and Biological Database","Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas","BCBInstitut","Inclusion Criteria:\n\n* Age\\> at 18 years old,\n* Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,\n* Patient in ICM at diagnosis\n\n  * a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or\n  * gynecological cancer (ovary, endometrium, cervix) or\n  * breast cancer or\n  * sarcoma.\n* Naïve patient of any treatment for the present cancer,\n* Patient requiring treatment involving at least one (or more) tumor surgery (s)\n* Patient who has accepted supplementary blood samples,\n* Patient having given his informed, written and express consent.\n\nExclusion Criteria:\n\n* Patient not affiliated to a social protection scheme,\n* Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons,\n* Pregnant and \u002F or nursing women,\n* Subject under tutelage, curatorship or safeguard of justice,\n* Patient in an emergency situation.","ALL","18 Years",{"count":65,"type":66},4000,"ESTIMATED","INTERVENTIONAL",[69],"NA","The BCB is a tool:\n\n* for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials;\n* to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations;\n* to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes.\n\nThe creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.",[72,73,74,75],"Digestive Cancer","Gynecologic Cancer","Breast Cancer","Sarcoma","2025-02-11",{"date":78,"type":79},"2025-02-12","ACTUAL",{"date":81,"type":79},"2017-07-27",{"date":83,"type":66},"2037-11",{"name":5,"class":6},1]